|
Human papillomavirus infection in metastatic lung adenocarcinoma is associated with better outcomes with immune checkpoint inhibitor treatment. |
|
Luis Leonardo Rojas Puentes |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Diana Carolina Mayorga Gonzalez |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Melissa Andrea Bravo Espinosa |
No Relationships to Disclose |
|
Zyanya Lucía Zatarain-Barron |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
Diana Carolina Sotelo Rodríguez |
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Mylan |
Speakers' Bureau - AstraZeneca; Boehringer Ingelheim; Guardant Health; MSD; Novartis |
Travel, Accommodations, Expenses - AstraZeneca |
(OPTIONAL) Uncompensated Relationships - Biomark (Inst); OncoDNA |
|
|
No Relationships to Disclose |
|
Andres Felipe Cardona Zorrilla |
Honoraria - Abbvie; Boehringer Ingelheim; Bristol-Myers Squibb; Celldex; Merck Sharp & Dohme; Roche |
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche |
Speakers' Bureau - Bristol-Myers Squibb; Foundation for Clinical and Applied Cancer Research (FICMAC); Foundation Medicine; Merck Sharp & Dohme; Novartis; Roche |
Travel, Accommodations, Expenses - Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Merck Sharp & Dohme; Roche |
|
|
No Relationships to Disclose |